Intravenous Immune Globulin Removed from World Market
نویسندگان
چکیده
منابع مشابه
CSL Behring Nanofiltered Immune Globulin Intravenous ( Human ) ,
DESCRIPTION Carimune® NF, Nanofiltered, Immune Globulin Intravenous (Human), is a sterile, highly purified polyvalent antibody product containing in concentrated form all the IgG antibodies which regularly occur in the donor population.1 This immunoglobulin preparation is produced by cold alcohol fractionation from the plasma of US donors. Part of the fractionation may be performed by another U...
متن کاملIntravenous immune globulin in chronic lymphocytic leukaemia.
The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patients. A randomized, double-blind study on 36 patients receiving either 500 mg/kg or 250 mg/kg IVIG...
متن کاملIntravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
OBJECTIVE The purpose of this study was to compare the efficacy and side effects of intravenous immunoglobulin (IVIG) with intravenous anti-D immunoglobulin for treatment of newly diagnosed acute childhood Idiopathic thrombocytopenic purpura (ITP). METHODS Children (6 months to 14 years) with newly diagnosed acute ITP and platelet count below 20,000/ microL were randomized to receive single d...
متن کاملIntravenous immune globulin in autoimmune and inflammatory diseases.
The Authors Reply: Both these letters ask whether there could be different interpretations of our results. In response to Thomas et al.: we first want to stress that we never claimed “a causal relationship between lower rates of criminality and pharmacologic treatment for ADHD.” However, we do think that the most plausible explanation is that medication reduces the risk. Thomas et al. argue tha...
متن کاملTreatment of neonatal sepsis with intravenous immune globulin.
BACKGROUND Neonatal sepsis is a major cause of death and complications despite antibiotic treatment. Effective adjunctive treatments are needed. Newborn infants are relatively deficient in endogenous immunoglobulin. Meta-analyses of trials of intravenous immune globulin for suspected or proven neonatal sepsis suggest a reduced rate of death from any cause, but the trials have been small and hav...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Infection Control & Hospital Epidemiology
سال: 1994
ISSN: 0899-823X,1559-6834
DOI: 10.1017/s0195941700009784